Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 850

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

Ye, Qing-Hai, Qin, Lun-Xiu, Forgues, Marshonna, He, Ping, Kim, Jin Woo, Peng, Amy C., Simon, Richard, Li, Yan, Robles, Ana I., Chen, Yidong, Ma, Zeng-Chen, Wu, Zhi-Quan, Ye, Sheng-Long, Liu, Yin-Kun, Tang, Zhao-You, Wang, Xin Wei·2003·Nature Medicine
DOI 10.1038/nm843
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm843

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Parkin, D.M., Pisani, P. & Ferlay, J. Global cancer statistics. CA Cancer J. Clin. 49, 33–64 (1999). · DOI · Paper page
  2. Pisani, P., Parkin, D.M., Bray, F. & Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83, 18–29 (1999). · DOI · Paper page
  3. El-Serag, H.B. & Mason, A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745–750 (1999). · DOI · Paper page
  4. Taylor-Robinson, S.D., Foster, G.R., Arora, S., Hargreaves, S. & Thomas, H.C. Increase in primary liver cancer in the UK, 1979-94. Lancet 350, 1142–1143 (1997). · DOI · Paper page
  5. Curley, S.A. et al. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann. Surg. 222, 375–380 (1995). · DOI
  6. Larcos, G., Sorokopud, H., Berry, G. & Farrell, G.C. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am. J. Roentgenol. 171, 433–435 (1998). · DOI
  7. Yang, B. et al. Prospective study of early detection for primary liver cancer. J. Cancer Res. Clin. Oncol. 123, 357–360 (1997). · DOI
  8. Izzo, F. et al. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann. Surg. 227, 513–518 (1998). · DOI
  9. Bolondi, L. et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48, 251–259 (2001). · DOI · Paper page
  10. Tang, Z.Y. Hepatocellular carcinoma-cause, treatment and metastasis. World J. Gastroenterol. 7, 445–454 (2001). · DOI · Paper page
  11. Zhou, X.D. et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 91, 1479–1486 (2001). · DOI · Paper page
  12. Yuki, K., Hirohashi, S., Sakamoto, M., Kanai, T. & Shimosato, Y. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66, 2174–2179 (1990). · DOI · Paper page
  13. Genda, T. et al. Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 30, 1027–1036 (1999). · DOI
  14. Mitsunobu, M., Toyosaka, A., Oriyama, T., Okamoto, E. & Nakao, N. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin. Exp. Metastasis 14, 520–529 (1996). · doi:10.1007/bf00115112
  15. Lindsay, C.K., Sinha, C.C. & Thorgeirsson, U.P. Morphological study of vascular dissemination in a metastatic hepatocellular carcinoma model in the monkey. Hepatology 26, 1209–1215 (1997). · DOI
  16. Kuriyama, S. et al. Analysis of intrahepatic invasion of hepatocellular carcinoma using fluorescent dye-labeled cells in mice. Anticancer Res. 18, 4181–4188 (1998).
  17. Osada, T. et al. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24, 1460–1467 (1996). · DOI
  18. Guo, X.Z. et al. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology 28, 1481–1488 (1998). · doi:10.1002/hep.510280606
  19. Hui, A.M., Li, X., Makuuchi, M., Takayama, T. & Kubota, K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int. J. Cancer 84, 604–608 (1999). · doi:10.1002/(sici)1097-0215(19991222)84:6<604::aid-ijc11>3.0.co;2-y
  20. Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470 (1995). · DOI · Paper page
  21. Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536–540 (2000). · DOI · Paper page
  22. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000). · DOI · Paper page
  23. Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000). · DOI · Paper page
  24. Pomeroy, S.L. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436–442 (2002). · DOI · Paper page
  25. Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68–74 (2002). · DOI · Paper page
  26. Okabe, H. et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61, 2129–2137 (2001).
  27. Xu, X.R. et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. USA 98, 15089–15094 (2001). · DOI · Paper page
  28. Radmacher, M.D., McShane, L.M. & Simon, R. A paradigm for class prediction using gene expression profiles. J. Comput. Biol. 9, 505–511 (2002). · DOI · Paper page
  29. Singhal, H. et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin. Cancer Res. 3, 605–611 (1997).
  30. Fedarko, N.S., Jain, A., Karadag, A., Van Eman, M.R. & Fisher, L.W. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res. 7, 4060–4066 (2001).
  31. Li, Y. et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J. Cancer Res. Clin. Oncol. (doi 10.1007/s00432-002-0396-4). · DOI · Paper page
  32. Qin, L.X. et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res. 59, 5662–5665 (1999).
  33. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000). · DOI · Paper page
  34. Sharp, J.A., Sung, V., Slavin, J., Thompson, E.W. & Henderson, M.A. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab. Invest. 79, 869–877 (1999).
  35. Urquidi, V. et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8, 61–74 (2002).
  36. Chen, H., Ke, Y., Oates, A.J., Barraclough, R. & Rudland, P.S. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oncogene 14, 1581–1588 (1997). · doi:10.1038/sj.onc.1200993
  37. Oates, A.J., Barraclough, R. & Rudland, P.S. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13, 97–104 (1996).
  38. Denhardt, D.T., Giachelli, C.M. & Rittling, S.R. Role of osteopontin in cellular signaling and toxicant injury. Annu. Rev. Pharmacol. Toxicol. 41, 723–749 (2001). · DOI · Paper page
  39. Weber, G.F. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta 1552, 61–85 (2001). · DOI
  40. Medico, E. et al. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth. Cancer Res. 61, 5861–5868 (2001).
  41. Edmondson, H.A. & Steiner, P.E. Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 7, 462–503 (1954). · DOI · Paper page
  42. Wu, C.G. et al. Distinctive gene expression profiles associated with hepatitis B virus x protein. Oncogene 20, 3674–3682 (2001). · DOI
  43. Brazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29, 365–371 (2001). · DOI · Paper page

Cited by

See all 850

Metadata

Authors
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., Ma, Z.-C., Wu, Z.-Q., Ye, S.-L., Liu, Y.-K., Tang, Z.-Y., & Wang, X. W.
Venue
Nature Medicine
Publisher
Springer Science and Business Media LLC
Published
2003-03-17
Volume
9
Issue
4
Pages
416-423
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
DOI
10.1038/nm843
OpenAlex
W2007601283
Cited by
850
References
2
FWCI
25.69
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.